LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.31 2.34

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.28

Max

1.32

Schlüsselkennzahlen
By Trading Economics
Einkommen	-147K -6.8M
Angestellte	42

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+190.7% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	4.7M 81M
Vorheriger Eröffnungskurs	-1.03
Vorheriger Schlusskurs	1.31

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Mai 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29. Mai 2026, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29. Mai 2026, 20:53 UTC

Ergebnisse

Oil Declines Lift Stocks to Fresh Records -- WSJ

29. Mai 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 20:33 UTC

Market Talk

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29. Mai 2026, 20:11 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 19:47 UTC

Ergebnisse

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29. Mai 2026, 19:36 UTC

Market Talk

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29. Mai 2026, 19:22 UTC

Market Talk

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29. Mai 2026, 19:05 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29. Mai 2026, 18:19 UTC

Market Talk

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29. Mai 2026, 18:12 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29. Mai 2026, 18:11 UTC

Market Talk

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29. Mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29. Mai 2026, 17:55 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

29. Mai 2026, 17:38 UTC

Market Talk

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29. Mai 2026, 17:00 UTC

Ergebnisse

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

29. Mai 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29. Mai 2026, 16:02 UTC

Market Talk

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Global Equities Roundup: Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Cryptocurrencies Appear Detached From Stocks -- Market Talk

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Cormetech Acquisition to Drive Growth

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Demand for AI Data Centers Insatiable

29. Mai 2026, 15:40 UTC

Market Talk

Kalshi To Launch Crypto Perpetual Futures -- Market Talk

29. Mai 2026, 15:20 UTC

Market Talk

Canada's Economy Not Looking All That Bright -- Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

190.7% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD 190.7%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.